3 Challenges to Patents on Therapeutic Monoclonal Antibodies
Three developments may have effects on the use of patents to fend off competition for therapeutic monoclonal antibodies.
remdesivir
-
Read more: 3 Challenges to Patents on Therapeutic Monoclonal Antibodies -
Read more: Experts Question FDA Approval of Remdesivir for COVID-19 Experts Question FDA Approval of Remdesivir for COVID-19
Experts are calling into question the recent decision of the U.S. Food and Drug Administration to approve remdesivir for the treatment of COVID-19.
-
Read more: New Study Provides Insights into Potential Regulatory Treatment of COVID-19 Drugs New Study Provides Insights into Potential Regulatory Treatment of COVID-19 Drugs
Pandemics like COVID-19 certainly require the prompt approval of treatments, but efficacy and safety should not come at the cost of speed.
